Package 65219-120-12

Brand: dalbavancin hydrochloride

Generic: dalbavancin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 65219-120-12
Digits Only 6521912012
Product NDC 65219-120
Product ID 65219-120_951cbf6d-768f-4a34-9ca9-fb87e2d30ab2
Description

1 VIAL in 1 PACKAGE (65219-120-12) / 25 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2025-11-10
Brand dalbavancin hydrochloride
Generic dalbavancin hydrochloride
Sample Package No

Linked Drug Pages (1)

DALBAVANCIN HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "951cbf6d-768f-4a34-9ca9-fb87e2d30ab2", "openfda": {"upc": ["0365219120124"], "unii": ["33WDQ7T81E"], "rxcui": ["1539243"], "spl_set_id": ["2c2ec45e-48a2-4887-8ab0-9244eb39a394"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 PACKAGE (65219-120-12)  / 25 mL in 1 VIAL", "package_ndc": "65219-120-12", "marketing_start_date": "20251110"}], "brand_name": "DALBAVANCIN HYDROCHLORIDE", "product_id": "65219-120_951cbf6d-768f-4a34-9ca9-fb87e2d30ab2", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Lipoglycopeptide Antibacterial [EPC]", "Lipoglycopeptides [CS]"], "product_ndc": "65219-120", "generic_name": "DALBAVANCIN HYDROCHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DALBAVANCIN HYDROCHLORIDE", "active_ingredients": [{"name": "DALBAVANCIN HYDROCHLORIDE", "strength": "500 mg/25mL"}], "application_number": "ANDA217591", "marketing_category": "ANDA", "marketing_start_date": "20251110", "listing_expiration_date": "20261231"}